NOV 05, 2018 10:00 AM PST

Drug Combination Halts The Progression of Fibrosis

WRITTEN BY: Nouran Amin

After seven years of research, scientists at Anglia Ruskin University, University College London and KU Leuven—developed a drug combination that holds a great deal of potential to halt the progression of Fibrosis.

Credit: Nordic Life Science

 

Initially, the researchers created a model that tests 21 different drugs to treat a disease in men called Peyronie's Disease. When tested on cells and animal models, they found that combining phosphodiesterase type 5 inhibitors (PDE5i) such as vardenafil (Levitra), sildenafil (Viagra) or tadalafil (Cialis) with selective estrogen receptor modulators (SERM) such as tamoxifen or raloxifene—treated fibrosis that causes Peyronie's Disease. Essentially, halting the progression.

 

"The principle of fibrosis is what causes Peyronie's Disease and so this is an important breakthrough. Although we do not believe this particular drug combination will be able to reverse the fibrotic process, it has the potential to treat all fibrotic diseases and halt progression,” says lead author Professor Selim Cellek, of Anglia Ruskin University. "This is an extremely exciting development and one that has taken several years of hard work. Fibrosis is a very serious condition that, when it affects a major organ, can be fatal.”

 

According to the study published in the journal European Urology, Fibrosis is known to cause half of all deaths. Responsible for conditions like cirrhosis of the liver, kidney, lung and heart—fibrosis occurs when damage causes a type of cell, called fibroblast, to convert itself into another type of cell called myofibroblast for the purpose of wound healing.

Image Credit: Promedior

After healing, the tissue that was previously damaged will return to its normal structure. However, in some cases that is not the case because the cells responsible, the myofibroblasts, will go out of control and 'overheal' the wound—causing scar tissue that holds no biological function.

 

Since scar tissue is dead tissue, its presence on major organs like the kidney, lungs, liver or heart, it is a serious tissue and estimated by the United States government cause 45% of all deaths. Developing a drug that can treat such an issue could save many lives. "To our knowledge, this is the first study of its kind to show a synergy between these two types of drugs. We look forward to taking this novel combination to clinical trials in the near future,” states Cellek.

Source: European Urology, Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 15, 2020
Immunology
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 02, 2020
Drug Discovery & Development
MAY 02, 2020
Glioblastoma Treatment Using Schizophrenic Drug Plus Radiation
A therapeutic used for the treatment of schizophrenia could be a gateway for targeting glioblastoma, one of the deadlies ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Hydrochloroquine Increases Risk of Death by COVID-19
Researchers have found that hydroxychloroquine is not an effective treatment for COVID-19. Their study found that it lea ...
MAY 28, 2020
Cancer
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
Loading Comments...